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Comparing Machine Learning Clustering with Latent Class Analysis on
Cancer Symptoms’ Data
Nikolaos Papachristou1, Christine Miaskowski2, Payam Barnaghi1, Roma Maguire1, Nazli Farajidavar1,
Bruce Cooper2 and Xiao Hu2
Abstract—Symptom Cluster Research is a major topic in
Cancer Symptom Science. In spite of the several statistical and
clinical approaches in this domain, there is not a consensus on
which method performs better. Identifying a generally accepted
analytical method is important in order to be able to utilize
and process all the available data. In this paper we report
a secondary analysis on cancer symptom data, comparing
the performance of five Machine Learning (ML) clustering
algorithms in doing so. Based on how well they separate specific
subsets of symptom measurements we select the best of them
and proceed to compare its performance with the Latent Class
Analysis (LCA) method. This analysis is a part of an ongoing
study for identifying suitable Machine Learning algorithms to
analyse and predict cancer symptoms in cancer treatment.
I. INTRODUCTION
One of the major advancements in the diagnosis, symptom
management and prognostication for cancer care has been
Symptom Cluster Research [1]–[3]. Under the NIH Panel
recommendations [4] clinicians use several assessment tools
for various symptoms throughout a cancer patient’s treat-
ment. On average, these patients report 10 unrelieved symp-
toms that have a negative impact on their functional status
and quality of life (QOL) [5]. For the patient populations that
specific symptom clusters are identified, clinicians can be in
a better position to apply interventions that are targeted both
at separate symptoms within a cluster (e.g. pain) as well
at the entire cluster (e.g. pain, fatigue, depression) [1]. If
these symptoms correspond to similar effects, for example
the symptoms of the aforementioned cluster, the individual
treatments for any of these symptoms separately can have
relieving effects on the symptom cluster as a whole [6]. So,
the pharmacologic agents used to alleviate symptoms can
affect independent symptoms as well as the collective effects
of a symptom cluster [1]. Nevertheless, cancer patients
experience such symptoms with a significant amount of
interindividual variability, with some of them experiencing
a few symptoms whereas others experience every symptom
associated with a given chemotherapy regimen [7]. Being
able to analyse the demographic and clinical characteristics
together with the molecular and behavioral profile of such
patients could help us identify distinct subgroups of patients
who will require more targeted symptom management inter-
ventions while undergoing cancer treatment.
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There are many different approaches, both clinical and
statistical, that are used on the field [3], [8], [9]. Clusters may
vary depending on the assessment tools, the disease stage
and type of cancer, the symptom domain used to cluster,
the statistical methodology and the numbers of symptoms
assessed. Furthermore, clusters may vary depending on the
conceptual approach selected, more specifically whether we
identify symptom clusters “de novo” or subgroups of pa-
tients based on their experiences within a specific symptom
cluster [9]. As there are no standardized accepted conceptual
approaches, statistical methods, assessment tools and symp-
tom domains yet, Symptom Cluster Research requires further
exploration before becoming part of the routine clinical care.
At the same time, advanced analytical techniques such
as Machine Learning (ML) and Data Mining (DM) are
constantly gaining popularity in providing insights into the
complex nature and mechanisms of clinical problems and are
used for building solutions for the critical decision making
inside the clinical setting [10]–[17]. Although similar, these
scientific methods have several significant distinctions from
statistics [16]. For example, Machine Learning and Data
Mining are more flexible about which methods to use,
adopting both mathematical and heuristic approaches, on
a specific dataset. Based on their superior computational
efficiency nonstatistical Machine Learning methods are able
to handle entire population of data samples, when statistics
typically uses only a fraction sample of such datasets.
Furthermore, while statistics usually handles quantified data,
Machine Learning and Data Mining can handle various kinds
of data (e.g. CT/MRI images, genomic data, sounds, text,
etc.). Lastly, although a hypothesis is needed in order to run
a statistical model, Machine Learning and Data Mining can
explore the data and discover hidden patterns from it. In
general, they seem to be more suitable and effective methods
to produce a general, underlying understanding out of a
specific, primary, complex set of data [16].
Drawing insights from the secondary analysis of past
collected cancer symptoms data [7], [18] this study provides
an evaluation of different ML algorithms in contrast to LCA,
which is one of the common analytical methods [8] for
identifying latent classes of patients based on their cancer
symptoms’ experience.
II. DATASET
Our dataset consists of oncology outpatients who were
under chemotherapy (CTX) [7], [19]. We used two simi-
lar datasets, named as N1 and N2, consisting of n1=582
and n2=1329 full patient registry records, respectively. The
datasets contained demographic information such as age,
sex, ethnicity, marital status, living arrangements, educa-
tion, employment status, and income. In order to assess
the patients’ functional status the Karnofsky performance
status (KPS) [20] scale was used. The Self-administered
Comorbidity Questionnaires [21] evaluated the occurrence,
treatment, and functional impact of comorbid conditions
(e.g., diabetes, arthritis). The Memorial Symptom Assess-
ment Scale (MSAS) [22] was used to evaluate the occur-
rence, severity, frequency, and distress of 32 cancer-related
symptoms. Patients were asked to specify whether they
had experienced each symptom within the past week (i.e.,
symptom occurrence) and rate its frequency of occurrence,
severity, and distress.
Although there is such a plethora of data, previous anal-
yses with LCA focused on a subset of the existing dataset,
which are reported in [18] and [7]. Our experiment entailed
the exploratory use of five different clustering algorithms on
this cancer symptom dataset. Their respective performances
were compared against each other and the algorithm with the
best overall performance was selected for further analyses
and comparison with the LCA method applied to the dataset
N2.
III. METHODS
A. Comparing ML clustering algorithms
Data was analysed using algorithms developed in Py-
Charm Professional Edition 4.5 and the Scikit-Learn li-
brary [23]. We explored dataset N1 (n1 samples x M
features) utilizing different subsets from it (n1 samples x
m features; m ≤M ).
Following the criterion used for LCA on similar datasets
in previous analyses [7], [18], we divided our dataset in
2 different subsets. We used the MSAS symptoms that
occurred at least in 30% (subset A = 25 Symptoms) and
40% (subset B = 15 Symptoms) of the patients. We ran
our analysis only on the occurrence measurements of these
symptoms, which take two discrete values “Yes” or “No”.
During this initial analysis, we utilised both subsets and
ran analyses with five different clustering algorithms (k-
Means [24], Birch [25], Spectral-Clustering [26], Hierar-
chical Agglomerative Clustering and k-Modes [27], [28]).
Following the LCA analysis on similar datasets, we preset
the number of clusters to three and four in two distinct
clusterings (3 for subset A, 4 for subset B) [7], [18].
We used k-Means [24] which is a centroid based al-
gorithm, clustering the samples into k groups of equal
variances. These clusters are described by the mean of the
samples inside them, which is called the cluster “centroid”.
k-Means aims at choosing centroids that minimise the within-
cluster sum-of-squares distance. Spectral-Clustering [26]
aims to cluster data that is connected but not necessarily
compact or clustered within convex boundaries. It is used
when the clusters are not linearly separated in the original
space, providing better results than algorithms such as k-
Means. In such occasions hierarchical clustering or density
based methods may also provide better results.
Birch [25] is a hierarchical clustering algorithm which can
provide an advantage in datasets which are non-uniformly
distributed and every data point is not equally important. It
concentrates on densely occupied partitions and following
a hierarchical order of analysis focuses on calculating and
updating measurements that capture the natural closeness of
data. Therefore, it is more robust to “noise” (data points
that are not part of the underlying pattern). Agglomerative
hierarchical clustering is a bottom-up clustering method
starting with every single data point in a single cluster.
In each successive iteration, it agglomerates (merges) the
closest pair of clusters by satisfying some similarity criteria,
until all of the data is in one cluster. A matrix tree plot
visually demonstrates the hierarchy within the final cluster,
where each merger is represented by a binary tree. Ag-
glomerative hierarchical clustering can produce an ordering
of the objects, which may be informative for data display.
Furthermore, smaller clusters can be generated, which may
be helpful for discovery.
Finally, k-Modes [27], [28], is used for clustering obser-
vations based on categorical variables. In comparison to k-
Means it defines clusters based on the number of matching
categories between data points and not on the Euclidean
distance. It is considered a more appropriate solution for
clustering categorical variables than k-Means. Its differences
with k-Means lie on using a matching dissimilarity measure
instead of the Euclidean distance between data points, replac-
ing means of clusters by modes and using a frequency-based
method to find the underlying modes for the final clusters of
data points [27].
The identified clusters were evaluated by their Silhouette
coefficient index [29], where the Jaccard similarity coeffi-
cient is used [30]. The Jaccard similarity coefficient is used
to compare both the similarity and diversity of sample sets. It
calculates similarity between fixed sample sets, and is defined
as the size of the intersection divided by the size of the union
of the sample sets.
J(A,B) =
|A ∩B|
|A ∪B|
=
|A ∩B|
|A|+ |B| − |A ∩B|
(1)
On the other hand, the Silhouette Coefficient is calculated
using the mean intra-cluster distance “a” and the mean
nearest-cluster distance “b” for each sample. The Silhouette
coefficient for a sample is:
a− b
max (a, b)
(2)
Where “b” is the distance between a sample and the nearest
cluster that the sample is not a member of. Silhouette
coefficient is defined only if the number of labels constrained
is:
2 ≤ nlabels ≤ nsamples − 1 (3)
The score is bounded between -1 for inappropriate clustering
and +1 for highly compact clustering. Scores around zero
Fig. 1. Clustering performance during initial analysis.
indicate overlapping clusters. In general the score is higher
when clusters are dense and well separated.
B. Comparing k-Modes with Latent Class Analysis
After evaluating the ML clustering methods to identify
the one(s) with the best performance, we proceeded our
experiment comparing symptom clusters made with k-Modes
and LCA. For our purpose, we used dataset N2. LCA and k-
Modes were used to evaluate whether they could produce
comparable findings. As our “gold” standard we used a
recent study by Miaskowski et al. [18] where 4 distinct
groups of patients were identified among cancer patients.
In order to have a sufficient number of patients with each
symptom we ran clustering on a total of 25 of 32 symptoms
from the MSAS that occurred in ≥ 30% of the patients.
In this paper we present the symptom occurrences of
only the 25 MSAS symptoms, based on the Physical and
Psychological MSAS subscales [22]. In our full study, which
is going to be presented in future work, we are exploring all
patient characteristics and compare the clinical relevance of
both analyses with descriptive statistics, means, and standard
deviations for quantitative variables and frequencies and
percentages for categorical variables. This specific analysis
was generated using SPSS version 22.
IV. RESULTS
A. Comparing ML clustering algorithms
We ran ten different analyses testing k-Means, Birch,
Spectral-Clustering, Hierarchical Agglomerative Clustering
and k-Modes on subset A (15 symptoms, prevalence ≥ 40%)
and subset B (25 symptoms, prevalence ≥ 30%). Taking
into account previous analyses on similar datasets of cancer
patients’ symptoms [7], [18], we ran our experiments under
the assumption of 3 or 4 pre-existing clusters among our
samples (3 for subset A, 4 for subset B). In overall, k-Modes
identified the most separable clusters (see Figure 1, Table I).
B. Comparing k-Modes with Latent Class Analysis
The 4 identified groups of patients were categorised in
accordance to the probability of their symptoms’ occurrence
within their cluster. The “ALL High” and “ALL Low” groups
included patients that reported high and low occurrence
rates of the 25 selected MSAS symptoms, respectively. The
TABLE I
PERFORMANCE OF THE CLUSTERING ALGORITHMS
Clustering
algorithms
Silhouette
Coefficient
(clusters = 3)
Silhouette
Coefficient
(clusters = 4)
K-Modes 0.169 0.191
Birch 0.141 0.163
Spectral 0.052 0.134
Agglomerative 0.160 0.175
k-Means 0.158 0.181
Fig. 2. Probability of symptom occurrence for K-Modes analysis
“Moderate Physical and High Psych” and “Moderate Phys-
ical and Low Psych” groups included patients that reported
moderate occurrence rates for the majority of the physical
symptoms (i.e., lack of energy, difficult concentrating, feeling
drowsy, nausea, pain, difficulty sleeping, dry mouth, lack of
appetite, change in the way food tastes, numbness/tingling,
hair loss, constipations, feeling bloated, changes in skin,
sweats, dizziness, hot flashes,, sexual problems, cough, di-
arrhea) and high or low occurrence rates, respectively, for
the psychological symptoms (i.e., worrying, feeling irritable,
feeling sad, feeling nervous, don’t look like myself).
The two methods performed similarly for the “ALL High”
and “ALL Low” groups, identifying two almost distinct clus-
ters (see Figures 2, 3). The two middle groups, “Moderate
Physical and Lower Psych” and “Moderate Physical and
High Psych ” had several overlaps among the probabilities
of their symptoms’ occurrence.
The “All Low” group consisted of 40.3% (n=536) of the
patients for the k-Modes analysis and 31.5% (n=419) for the
LCA. Probability of occurrence for the MSAS symptoms for
this group ranged from 0.647 to 0.093 for k-Modes and from
0.549 to 0.064 for LCA. The “ALL High” group was the
smallest for LCA (13.4%, n=178) and the second biggest for
k-Modes (23.2%, n=308). Probability of occurrence for the
MSAS symptoms for this group ranged from 0.974 to 0.429
for k-Modes and from 0.994 to 0.562 for LCA. The second
Fig. 3. Probability of symptom occurrence for Latent Class Analysis
largest separated group for LCA was the “Moderate Physical
and High Psych” one, consisting of 31.3% (n=416) of the
patients. In contrast the same group was the third largest
identified for k-Modes with 21.1% (n=279) of the patients.
The probability of occurrence for the MSAS symptom ranged
from 0.93 to 0.293 for LCA and from 0.939 to 0.236 for k-
Modes. For both analyses, there were moderate occurrence
rates for the majority of the physical symptoms, ranging from
0.939 to 0.236 for k-Modes and from 0.93 to 0.293 for LCA,
and high occurrence rates for the psychological symptoms
ranging from 0.811 to 0.582 for k-Modes and from 0.906 to
0.541 for LCA. The third largest group (23.8%, n=316) for
LCA was the “Moderate Physical and Lower Psych” class
while the same group was the smallest one for k-Modes
(15.4%, n=205). Probability of occurrence for the MSAS
symptoms for this class ranged from 0.956 to 0.185 for k-
Modes and from 0.987 to 0.142 for LCA. The probability of
occurrence for the physical symptoms ranged from 0.956 to
0.21 for k-Modes and from 0.987 to 0.241 for LCA. For the
psychological symptoms the range was from 0.278 to 0.185
for k-Modes and from 0.282 to 0.142 for LCA.
V. CONCLUSIONS
We investigated the performance of readily Machine
Learning algorithms in relation to common practice statistical
methods, such as LCA. The results of our study were in
congruence with the hypothesis and the findings of four
distinct subgroups of cancer patients that were made with
the LCA method and the clinical observations by Miaskowski
et al. [18]. Our proposed model provides highly compatible
results with LCA, being capable of automated grouping
of patients also. We have initiated a comparison among
different clustering algorithms on cancer symptom datasets
based on the hypothesis that Symptom Cluster Research will
benefit from exploring all the multivariate versions of these
datasets, taking the domain a step forward from utilising only
categorical variables such as symptoms prevalence, distress
and discomfort levels. Although this experiment is only
based on categorical variables, the aforementioned principal
is the base of ongoing experiments, taking advantage the
multivariate nature of different ML methods.
In the era of precision medicine [31] and big data [32],
coupled with the use of electronic medical records [33] and
smart phone technology [34], [35], it can be assumed that
symptom data will be collected in real time from oncology
patients receiving CTX. The application of more sophisti-
cated algorithms with analytical techniques such as Machine
Learning will allow clinicians to assess patients’ phenotypic
and molecular data on an ongoing basis. The integration of
these types of information across multiple patients will assist
clinicians to identify patients at highest risk for the most
severe symptom profiles and to treat their most common and
severe symptoms on a more timely and effective manner.
This type of risk profiling and aggressive symptom manage-
ment could reduce oncology patients’ symptom burden and
improve their QOL.
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